Markets

Health & Pharma

Biotech, pharmaceutical and medtech news: clinical trials, approvals, deals and healthcare markets.

Health & Pharma

Navigating Medicare Gaps: Dave Ramsey’s Essential Guide for Retirees to Secure Comprehensive Healthcare Coverage

Financial expert and radio personality Dave Ramsey is cautioning retirees about a crucial Medicare oversight that could impact their healthcare coverage. While Medicare provides essential health services for Americans aged 65 and older, Ramsey emphasizes that the federal program leaves significant gaps in coverage that seniors need to address proactively.

Silexion Therapeutics Strengthens Leadership with Appointment of Renowned Cancer Expert Prof. Amnon Peled to Board of Directors
Health & Pharma

Silexion Therapeutics Strengthens Leadership with Appointment of Renowned Cancer Expert Prof. Amnon Peled to Board of Directors

Silexion Therapeutics (NASDAQ: SLXN), a trailblazer in RNA interference (RNAi) therapies targeting KRAS-driven cancers, has announced the appointment of Prof. Amnon Peled to its Board of Directors. Prof. Peled, an internationally acclaimed authority in stem cell biology, immunology, and cancer therapeutics, brings decades of expertise in advancing novel cancer

Health & Pharma

“Mastering Medicare: Essential Enrollment Strategies to Avoid Costly Mistakes”

Financial expert Dave Ramsey is cautioning seniors about a crucial decision regarding their Medicare enrollment timing that could have lasting financial consequences. The enrollment process for Medicare contains multiple deadlines and requirements that retirees need to carefully navigate to avoid permanent penalties. According to Ramsey, the Medicare system’s complexity

Aurigene’s Breakthrough CAR-T Therapy: Dr. Reddy’s Laboratories Unveils Promising Phase 1 Results in Fight Against Multiple Myeloma
Health & Pharma

Aurigene’s Breakthrough CAR-T Therapy: Dr. Reddy’s Laboratories Unveils Promising Phase 1 Results in Fight Against Multiple Myeloma

Aurigene Oncology Limited, a subsidiary of Dr. Reddy’s Laboratories (BSE: DRREDDY) (NASDAQ: RDY), has unveiled promising results from its Phase 1 trial of Ribrecabtagene autoleucel (DRL-1801) — India’s first novel autologous BCMA-directed CAR-T cell therapy for patients with relapsed or refractory multiple myeloma. This development marks

Health & Pharma

Revolutionizing Healthcare: Medtronic’s Bold AI Strategy for Enhanced Patient Care and Operational Efficiency

Medical device manufacturer Medtronic is taking an ambitious approach to integrating artificial intelligence across its operations. The company has tasked every department with devising ways to leverage AI for enhancing productivity and improving patient care. This initiative has already generated over 200 ideas from employees, with several receiving initial internal